Ann: Advanced development of Felix device supported by R&D rebate, page-6

....or quietly getting oln with the job?
I'll be interested to learn about/see the next set of test results for Felix and to hear management's plans to raise enough capital to get the Felix device to market, given recent ANN:  
"....Research and Development tax refund of $431,528.70.  Memphasys intends to apply these funds to further develop its ‘Felix’ device and for working capital purposes."
I'm guessing that at some stage in the next 6 months or so we'll need to raise more funds.  For us long termers that probably means further unwelcome dilution, unless we have additional spare cash to tip in.
BTW I'm not sure why our SP sits so low at present.  Before we got involved with the "loan sharks" we were sitting at plus or minus 4 cents for a long long while, which seemed to me fair value to me given the entanglements with legacy /PrIME issues.
However now (even given the dilution the loan sharks caused) with the litigation and the last of the legacy issues behind us, I would have expected an SP of between 1 and 2 cents until such time as we bring the Felix device to market or announce some new contract....but we are still languishing at only .003!
It seems that although everyone loves the tech the same can't be said for management.  That is a little unfair in my view.  I suspect the original plan by our former Board was to set up NuSep to fail shortly after the spin out of PrIME.  If not for the commitment, tenacity and monetary support of both  AG and AC, I suspect we would have done our dough moons ago with the coy turning turtle.
I feel pretty confident now that a new era has begun, but that doesn't mean that our Board doesn't face real challenges in bringing home the bacon for us.  At least now they don't have one hand tied behind their backs as well as their legs bound together as they strive to move our company forward.  
GLTA.
Kind regards,